BIO International Convention

BIO 2026 in San Diego is built around connecting innovators, investors, pharma/biotech leaders, academia, government and non-profits—supported by a packed agenda of education sessions, company presentations and a large exhibition, alongside a proprietary partnering platform designed to help attendees schedule high-value business meetings.

Who the audience is and how many attend

Audience

• Biotech and pharma leadership teams, including business development and partnering
• Investors (VC, growth equity, strategic investors) and deal teams
• R&D leaders and scientific innovators across therapeutic areas and modalities
• CDMOs, service providers and enabling technology companies
• Academia, non-profits and government agencies supporting biotech innovation

Scale

• Industry leaders: ~20,000 (commonly cited for BIO)
• Exhibitors: 1,650+ (recent edition reference shared by BIO)
• Partnering meetings: 66,000+ (recent edition reference shared by BIO)

What to expect

• Four days of education sessions, main-stage programming and company presentations alongside a major exhibition
• High-density business development and partnering, including scheduled 1:1 meetings via BIO Partnering™ (available with specific registration tiers)
• A global community presence, with extensive networking designed for collaboration, licensing and investment conversations